Organogenesis Holdings Inc.
ORGO
$1.79
$0.031.71%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 5.90% | 11.73% | 16.80% | 2.10% | -4.26% |
| Total Other Revenue | 1,157.08% | -- | -- | -- | -- |
| Total Revenue | 6.50% | 12.19% | 17.04% | 2.24% | -4.21% |
| Cost of Revenue | 19.44% | 21.33% | 14.34% | 5.51% | -2.02% |
| Gross Profit | 2.09% | 9.29% | 17.89% | 1.16% | -4.93% |
| SG&A Expenses | 2.25% | 8.04% | 10.60% | 6.88% | 7.16% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.43% | 10.64% | 9.14% | 4.68% | 2.19% |
| Operating Income | -95.88% | 147.62% | 186.11% | -88.49% | -205.03% |
| Income Before Tax | -61.39% | 117.65% | 1,773.32% | 58.24% | -65.17% |
| Income Tax Expenses | 471.07% | 118.66% | 370.94% | 3.57% | -480.07% |
| Earnings from Continuing Operations | -922.43% | 117.12% | 4,201.05% | 113.62% | 50.25% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -922.43% | 117.12% | 4,201.05% | 113.62% | 50.25% |
| EBIT | -95.88% | 147.62% | 186.11% | -88.49% | -205.03% |
| EBITDA | -406.41% | 42.68% | 107.98% | -31.95% | -89.45% |
| EPS Basic | -536.31% | 10.48% | 2,100.00% | -92.47% | -3.37% |
| Normalized Basic EPS | -90.13% | 257.97% | 229.73% | -65.73% | -221.90% |
| EPS Diluted | -511.67% | 3.95% | 670.81% | -86.17% | -3.16% |
| Normalized Diluted EPS | -111.87% | 191.28% | 215.53% | -74.84% | -225.41% |
| Average Basic Shares Outstanding | -1.00% | -2.43% | -3.75% | -3.45% | -2.14% |
| Average Diluted Shares Outstanding | 0.06% | -1.38% | -2.70% | -2.65% | -1.98% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |